Sun Pharmaceutical Calls Surge with 15,216 Contracts at Rs 1,740 Strike Price

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the market today, particularly in the options segment. The company, operating within the Pharmaceuticals & Biotechnology industry, has seen significant trading activity in its call options, with 15,216 contracts traded at a strike price of Rs 1,740. This activity has generated a turnover of approximately Rs 1,282.97 lakhs, reflecting robust investor engagement. As of the latest data, the underlying value of Sun Pharma stands at Rs 1,742.20, indicating a slight premium over the strike price. The open interest for these options is recorded at 3,592 contracts, suggesting a healthy level of interest among traders. In terms of performance, Sun Pharmaceutical has outperformed its sector by 0.71% today, with a 1.57% increase in its stock price. The stock has been on a positive trajectory, gaining for four consecutive days and accumulating a total return of 3.42% during this period. Notably, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. However, it is worth noting a decline in delivery volume, which has decreased by 11.27% compared to the 5-day average, with a delivery volume of 9.1 lakhs recorded on November 11. Despite this, the stock remains liquid enough for trades of Rs 6.62 crore, based on 2% of the 5-day average traded value. In summary, Sun Pharmaceutical Industries Ltd continues to demonstrate notable activity and resilience in the market, supported by strong trading metrics and a solid performance relative to its sector.